Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month. It works both ways. Lenacapavir is in a brand new class of drugs called a ...

* Scientists used a natural RNA to suppress HIV's reactivation * It acts like a brake mechanism to stop viral activity * Could lead to a permanent treatment strategy in the //future A promising study ...

A single positive HIV viral load test often falsely identified HIV infection in people who were using long-acting cabotegravir (Apretude) for preexposure prophylaxis (PrEP), according to results from ...

There are many molecules with therapeutic potential, but it can be a challenge to deliver them to the right places at the right times. RNA is one such molecule; the sequences for different proteins ...

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines. RNA-based medicines are one of the most promising ways to fight human disease, as ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...